GKOS · Glaukos Corp
United States · RS rating 91 · As of 2026-10-14
| Price | 167.89 USD |
|---|---|
| 1-day change | +1.4% |
| RS rating (overall / 1M / 3M / 12M) | 91 / 51 / 84 / 95 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 45 / 68 / 31 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | -728.6% |
| Sales growth Q/Q | +7.2% |
| Distance from 52-week high | +11.4% |
| Market cap (USD) | $7.1B |